(Q36384679)

English

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989. (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

autotransplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

4

object named as

Frits van Rhee

0 references

1

object named as

Bart Barlogie

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

14

object named as

Antje Hoering

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

6

object named as

Elias Anaissie

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

Maurizio Zangari

10

object named as

Maurizio Zangari

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

author name string

Guido Tricot

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jeff Haessler

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Michele Cottler-Fox

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

James Waldron

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mauricio Pineda-Roman

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Raymond Thertulien

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Klaus Hollmig

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Abid Mohiuddin

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Yazan Alsayed

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

John Crowley

15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jeffrey Sawyer

16

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

25 September 2007

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

111

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

94-100

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

The biology of alkylating-agent cellular injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Leukemia following Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

30 September 2017

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

28 June 2018

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

28 June 2018

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Transplantation as salvage therapy for high-risk patients with myeloma in relapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2200826

21 September 2018

MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic findings in 200 patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total therapy with tandem transplants for newly diagnosed multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17895401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2007-06-097444

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

release_tt3otriosrd75jfc5p2vrabn2u

1 reference

https://api.fatcat.wiki/v0/release/tt3otriosrd75jfc5p2vrabn2u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36384679&oldid=1844485104"